ADVERTISEMENT
cans of food seen from the top
A Landmark Study On BPA Leaves Scientists at Odds
Conceived as a way to resolve differences between government regulators and academics over the chemical’s effects, the CLARITY-BPA collaboration instead highlights divisions.
A Landmark Study On BPA Leaves Scientists at Odds
A Landmark Study On BPA Leaves Scientists at Odds

Conceived as a way to resolve differences between government regulators and academics over the chemical’s effects, the CLARITY-BPA collaboration instead highlights divisions.

Conceived as a way to resolve differences between government regulators and academics over the chemical’s effects, the CLARITY-BPA collaboration instead highlights divisions.

policy, regulation, public health, disease & medicine

Questions Raised About “Breakthrough” Therapies’ Clinical Support
Catherine Offord | Jul 17, 2018 | 2 min read
Compared to other drugs, therapeutics given breakthrough status receive FDA approval on the basis of weaker trial evidence, a study finds.
FDA Approves First Marijuana-Derived Drug
Shawna Williams | Jun 25, 2018 | 2 min read
As the CBD-based medication enters the market, the agency promises a crackdown on producers of cannabidiol products that make unproven claims.
ADVERTISEMENT